Objective: To investigate the performance (safety) of the GlucoTab system for glycaemic management in non-critically ill patients with type 2 diabetes at the general ward

Inclusion Criteria:

• Informed consent obtained after being advised of the nature of the study
• Male or female aged 18 - 90 years (both inclusive)
• Type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four

Exclusion Criteria:

• Impaired renal function (serum creatinine ≥3.0mg/dL)
• Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
• Pregnancy
• Any mental condition rendering the patient incapable of giving his consent
• Terminally ill patients
• Participation in a trial within 3 months prior to this trial
• Known or suspected allergy to insulin